A randomized controlled trial comparing the effect of intravenous, subcutaneous, and intranasal fentanyl for pain management in patients undergoing cesarean section

Jabalameli, Mitra; Talakoub, Reihanak; Abedi, Bita; Ghofrani, Zahra

A randomized controlled trial comparing the effect of intravenous, subcutaneous, and intranasal fentanyl for pain management in patients undergoing cesarean section

Authors

¹ Department of Anesthesiology, Isfahan University of Medical Sciences, Isfahan, Iran

² Department of Anesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: The objective of this study was to evaluate and compare the effects of three methods of using intravenous (IV), subcutaneous and intranasal (IN) fentanyl for pain management following general anesthesia in patients undergoing cesarean section.
Materials and Methods: A prospective, randomized, single-blind clinical trial was done on 75 patients aged 20–40 years, American Society of Anesthesiology-1, who had a normal singleton pregnancy beyond 36 weeks of gestational age. Patients were randomized to receive 50 μg fentanyl intravenously (Group 1), subcutaneously (Group 2) or intranasally (Group 3) after closure of incision. The pain intensity, nausea, the systolic, and diastolic blood pressures were assessed.
Results: All groups were equivalent for baseline characteristics. The average pain visual analog scale (VAS) score was less in the second group who received fentanyl subcutaneously at the time of recovery admission (6.8 ± 1.5) (P = 0.037) and after 3 h (6.36 ± 1.5) (P = 0.033) postoperatively. The mean VAS score of nausea and the mean systolic and diastolic blood pressures were not significantly different between three groups throughout the study (P > 0.05).
Conclusion: subcutaneous fentanyl is an effective alternative to IV and IN route of administration for pain management.

Keywords

References

1.	Mathai M, Hofmeyr GJ, Mathai NE. Abdominal surgical incisions for caesarean section. Cochrane Database Syst Rev 2013;5:CD004453.
2.	Betrán AP, Merialdi M, Lauer JA, Bing-Shun W, Thomas J, Van Look P, et al. Rates of caesarean section: Analysis of global, regional and national estimates. Paediatr Perinat Epidemiol 2007;21:98-113.
3.	Bragg F, Cromwell DA, Edozien LC, Gurol-Urganci I, Mahmood TA, Templeton A, et al. Variation in rates of caesarean section among English NHS trusts after accounting for maternal and clinical risk: Cross sectional study. BMJ 2010;341:c5065.
4.	Mathai M, Hofmeyr GJ. Abdominal surgical incisions for caesarean section. Cochrane Database Syst Rev 2007;1:CD004453.
5.	Ahmad-Nia S, Delavar B, Eini-Zinab H, Kazemipour S, Mehryar AH, Naghavi M. Caesarean section in the Islamic republic of Iran: Prevalence and some sociodemographic correlates. East Mediterr Health J 2009;15:1389-98.
6.	Comerford D. Techniques of opioid administration. Anaesth Intensive Care Med 2008;9:21-6.
7.	Dale O, Hjortkjaer R, Kharasch ED. Nasal administration of opioids for pain management in adults. Acta Anaesthesiol Scand 2002;46:759-70.
8.	Prommer E, Thompson L. Intranasal fentanyl for pain control: Current status with a focus on patient considerations. Patient Prefer Adherence 2011;5:157-64.
9.	Toussaint S, Maidl J, Schwagmeier R, Striebel HW. Patient-controlled intranasal analgesia: Effective alternative to intravenous PCA for postoperative pain relief. Can J Anaesth 2000;47:299-302.
10.	Christrup LL, Foster D, Popper LD, Troen T, Upton R. Pharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: A randomized, double-blind, double-dummy, two-way, crossover study. Clin Ther 2008;30:469-81.
11.	Twycross R, Prommer EE, Mihalyo M, Wilcock A. Fentanyl (transmucosal). J Pain Symptom Manage 2012;44:131-49.
12.	Grarup J, Nielsen HW. Fentanyl Composition for Nasal Administration. Google Patents; 2011.
13.	Herz A, Teschemacher H. Activities and sites of antinociceptive action of morphine-like analgesics and kinetics of distribution following intravenous, intracerebral and intraventricular application. Adv Drug Res 1971;6:79-119.
14.	Floyd JL. The pharmacologic approach to the critically ill patient. Anesth Analg 1989;68:75-6.
15.	Wenderoth BR, Kaneda ET, Amini A, Amini R, Patanwala AE. Morphine versus fentanyl for pain due to traumatic injury in the emergency department. J Trauma Nurs 2013;20:10-5.
16.	Davies A, Sitte T, Elsner F, Reale C, Espinosa J, Brooks D, et al. Consistency of efficacy, patient acceptability, and nasal tolerability of fentanyl pectin nasal spray compared with immediate-release morphine sulfate in breakthrough cancer pain. J Pain Symptom Manage 2011;41:358-66.
17.	Soares LG, Martins M, Uchoa R. Intravenous fentanyl for cancer pain: A “fast titration” protocol for the emergency room. J Pain Symptom Manage 2003;26:876-81.
18.	Zeppetella G. Opioids for cancer breakthrough pain: A pilot study reporting patient assessment of time to meaningful pain relief. J Pain Symptom Manage 2008;35:563-7.
19.	Zarth R, Ehmer M, Sittig HB. Oral transmucosal fentanyl citrate for the treatment of breakthrough pain: Results of a non-interventional study (NIS). Acute Pain 2008;10:45.
20.	Borland ML, Bergesio R, Pascoe EM, Turner S, Woodger S. Intranasal fentanyl is an equivalent analgesic to oral morphine in paediatric burns patients for dressing changes: A randomised double blind crossover study. Burns 2005;31:831-7.
21.	Finn J, Wright J, Fong J, Mackenzie E, Wood F, Leslie G, et al. A randomised crossover trial of patient controlled intranasal fentanyl and oral morphine for procedural wound care in adult patients with burns. Burns 2004;30:262-8.
22.	Capper SJ, Loo S, Geue JP, Upton RN, Ong J, Macintyre PE, et al. Pharmacokinetics of fentanyl after subcutaneous administration in volunteers. Eur J Anaesthesiol 2010;27:241-6.
23.	Watanabe S, Pereira J, Hanson J, Bruera E. Fentanyl by continuous subcutaneous infusion for the management of cancer pain: A retrospective study. J Pain Symptom Manage 1998;16:323-6.
24.	Życzkowska J, Wordliczek J. Subcutaneous and intravenous administration of analgesics in palliative medicine. Adv Palliat Med 2009;8:153-60.

Advanced Biomedical Research